Head-to-head comparison of limus- versus paclitaxel-coated balloons in the treatment of in-stent restenosis: a meta-analysis. [PDF]
Sagris M +9 more
europepmc +1 more source
Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes. [PDF]
Sella G +18 more
europepmc +1 more source
Retrospective Analysis of In-Stent Restenosis in Diabetic Patients. [PDF]
Khalid H +6 more
europepmc +1 more source
The impact of metabolic syndrome and triglyceride-glucose index on the risk of in-stent restenosis after percutaneous coronary intervention: a retrospective study. [PDF]
Han L, Chen Y, Xu L, Chen W.
europepmc +1 more source
The association between glycated hemoglobin levels and in-stent restenosis following percutaneous coronary intervention in coronary artery disease patients. [PDF]
Lei Y +8 more
europepmc +1 more source
Remnant Cholesterol as a Predictor of Target-Vessel Failure in Patients With In-Stent Restenosis. [PDF]
Kong XH +10 more
europepmc +1 more source
Immune dysregulation complicated by recurrent in-stent restenosis in patients with multivessel coronary artery disease: a case report. [PDF]
Jiang J +9 more
europepmc +1 more source
Outcomes of Drug-Coated Balloon Versus Drug-Eluting Stent for In-Stent Restenosis and De-Novo Lesions: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Moghadam AS +19 more
europepmc +1 more source
Reply to Letter to the Editor: "Comments on 'Evaluation of Whole Blood Viscosity to Predict Stent Restenosis'". [PDF]
Çalapkulu Y.
europepmc +1 more source
Drug-coated balloons in coronary in-stent restenosis: a systematic review and meta-analysis comparing sirolimus and biolimus with paclitaxel platforms. [PDF]
Dandamudi M +8 more
europepmc +1 more source

